Delivery Order SPE2DB20D1100-SPE2DB25FB7F3
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$45K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FW0RQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fingolimod 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $37,938.28 and a completion date of May 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,817.40 firm-fixed-price contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fingolimod 0.5 mg capsules, a medication used for the treatment of multiple sclerosis. The contract has a ceiling value of $5,916.96 and a period of performance through April 14, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fingolimod 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a firm fixed price of $3,596.00 and a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,526.70 Firm Fixed Price Delivery Order covers the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain neurological conditions. The contract has a ceiling value of $16,009.46 and a performance period ending on June 24, 2025. This award is not designated as a set-aside contract, indicating open...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has a ceiling value of $3,666.91 and a period of performance through June 14, 2023. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,535.90 firm fixed-price contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, with a period of performance through May 29, 2025. The contract award is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a neurological medication, with a ceiling value of $28,649.02. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. This contract is not designated as a set-aside and was likely competed openly. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,811.90, is for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...